Toggle Main Menu Toggle Search

ePrints

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

Lookup NU author(s): Dr Deborah Stocken

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

We undertook a comprehensive analysis of circulating myeloid-derived suppressor cells (MDSCs) and T regulatory cells (Tregs) in pancreatic, esophageal and gastric cancer patients and investigated whether MDSCs are an independent prognostic factor for survival. We evaluated a series of plasma cytokines and in particular re-evaluated the Th2 cytokine interleukin-13 (IL-13). Peripheral blood was collected from 131 cancer patients (46 pancreatic, 60 esophageal and 25 gastric) and 54 healthy controls. PBMC were harvested with subsequent flow cytometric analysis of MDSC (HLADR− Lin1low/− CD33+ CD11b+) and Treg (CD4+ CD25+ CD127low/− FoxP3+) percentages. Plasma IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-17, G-CSF, IFN-γ, TNF-α and VEGF levels were analyzed by the Bio-Plex cytokine assay. Plasma arginase I levels were analyzed by ELISA. MDSCs and Tregs were statistically significantly elevated in pancreatic, esophageal and gastric cancer compared with controls, and MDSC numbers correlated with Treg levels. Increasing MDSC percentage was associated with increased risk of death, and in a multivariate analysis, MDSC level was an independent prognostic factor for survival. A unit increase in MDSC percentage was associated with a 22% increased risk of death (hazard ratio 1.22, 95% confidence interval 1.06–1.41). Arginase I levels were also statistically significantly elevated in upper gastrointestinal cancer patients compared with controls. There was Th2 skewing for cytokine production in all three diseases, and importantly there were significant elevations of the pivotal Th2 cytokine interleukin-13, an increase that correlated with MDSC levels.


Publication metadata

Author(s): Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW

Publication type: Article

Journal: Cancer Immunology, Immunotherapy

Year: 2011

Volume: 60

Issue: 10

Pages: 1419-1430

Print publication date: 05/06/2011

ISSN (print): 0340-7004

ISSN (electronic): 1432-0851

Publisher: Springer

URL: http://dx.doi.org/10.1007/s00262-011-1028-0

DOI: 10.1007/s00262-011-1028-0


Altmetrics

Altmetrics provided by Altmetric


Actions

    Link to this publication


Share